loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Imatinib NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Dr.Reddy's Laboratories Limited (1)

02 Aurobindo Pharma Limited (1)

03 BLUEBAY SHANDONG CO.,LTD (1)

04 DARMERICA, LLC (1)

05 F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. (2)

06 Formosa Laboratories, Inc. (1)

07 Hetero Labs Limited (1)

08 Hubei Biocause Heilen Pharmaceutical Co., Ltd (1)

09 LAURUS LABS LIMITED (1)

10 Laurus Labs Limited (1)

11 MSN Laboratories Private Limited (2)

12 Natco Pharma Limited (1)

13 Pliva Croatia Ltd (1)

14 SHILPA PHARMA LIFESCIENCES LIMITED (2)

15 SUN PHARMACEUTICAL INDUSTRIES, INC. (1)

16 Sterling Pharma Solutions Limited (1)

17 Valary Lab Private Limited (1)

18 zhejiang jiuzhou pharmaceutical Co., Ltd. (1)

filter

01 IMATINIB (1)

02 IMATINIB MESILATE (1)

03 IMATINIB MESYLATE (1)

04 Imatinib (2)

05 Imatinib Mesylate (12)

06 Imatinib Mesylate (IMA) (1)

07 Imatinib Mesylate (IMN) (1)

08 Imatinib mesylate (2)

filter

01 China (3)

02 Croatia (1)

03 India (11)

04 Italy (2)

05 Taiwan (1)

06 U.S.A (1)

07 United Kingdom (1)

08 Blank (1)

URL Supplier Web Content
NA Not Available For Sales
Imatinib Mesylate
POWDER (1kg/kg)
BULK INGREDIENT
55111-939
2011-03-30
2024-12-31
URL Supplier Web Content
Imatinib Mesylate
POWDER (50kg/50kg)
BULK INGREDIENT
59651-610
2024-01-05
2025-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
IMATINIB
POWDER (1kg/kg)
BULK INGREDIENT
48087-0143
2018-12-20
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
IMATINIB MESILATE
POWDER (1kg/kg)
BULK INGREDIENT
48087-0121
2018-12-20
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
IMATINIB MESYLATE
POWDER (1kg/kg)
BULK INGREDIENT
42385-720
2013-05-09
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Imatinib Mesylate
POWDER (1kg/kg)
BULK INGREDIENT
42385-316
2013-05-09
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Imatinib Mesylate
POWDER (1kg/kg)
BULK INGREDIENT
54893-0066
2017-12-29
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Imatinib Mesylate
POWDER (1kg/kg)
BULK INGREDIENT
54893-0005
2011-10-13
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Imatinib Mesylate
POWDER (100kg/100kg)
BULK INGREDIENT
11722-052
2011-12-09
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Imatinib mesylate
POWDER (640kg/640kg)
BULK INGREDIENT
50384-6200
2023-07-03
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 220127-57-1 / Imatinib Mesylate API manufacturers, exporters & distributors?

Imatinib Mesylate manufacturers, exporters & distributors 1

82

PharmaCompass offers a list of Imatinib Mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imatinib Mesylate manufacturer or Imatinib Mesylate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imatinib Mesylate manufacturer or Imatinib Mesylate supplier.

PharmaCompass also assists you with knowing the Imatinib Mesylate API Price utilized in the formulation of products. Imatinib Mesylate API Price is not always fixed or binding as the Imatinib Mesylate Price is obtained through a variety of data sources. The Imatinib Mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Imatinib Mesylate

Synonyms

220127-57-1, Gleevec, Glivec, Imatinib mesilate, Sti-571, Imatinib methanesulfonate

Cas Number

220127-57-1

Unique Ingredient Identifier (UNII)

8A1O1M485B

About Imatinib Mesylate

A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.

Imatinib Manufacturers

A Imatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imatinib, including repackagers and relabelers. The FDA regulates Imatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Imatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Imatinib Suppliers

A Imatinib supplier is an individual or a company that provides Imatinib active pharmaceutical ingredient (API) or Imatinib finished formulations upon request. The Imatinib suppliers may include Imatinib API manufacturers, exporters, distributors and traders.

click here to find a list of Imatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Imatinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Imatinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Imatinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Imatinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Imatinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Imatinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Imatinib suppliers with NDC on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY